PERFECT Project - Part 2 - Study 1

January 19, 2023 updated by: University of Manitoba

Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 1

The objectives are to test the acute effects of different extruded pulse snacks on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite on an aerobic exercise session, and 3) food intake two hours following the exercise session. The investigators hypothesize that consumption of food products containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. The investigators also hypothesize that consumption of extruded pulse snacks will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R3T 2N2
        • Richardson Centre for Functional Foods and Nutraceuticals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Normoglycemic (<5.6 mmol/L) and normotensive (systolic blood pressure <140 mm Hg and diastolic blood pressure below < 90 mm Hg)
  • BMI of 18.5-29.9 kg/m2

Exclusion Criteria:

  • Restrained eaters
  • Regularly skip breakfast
  • Smokers
  • Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity)
  • Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.
  • Those unable to walk for an hour continuously

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Extruded snack control
100% corn flour
Non pulse extruded snack
Experimental: Extruded snack with small particle size pea flour
60% corn flour and 40% small particle size pea flour
Pulse extruded snack
Experimental: Extruded snack with large particle size pea flour
60% corn flour and 40% large particle size pea flour
Pulse extruded snack
Experimental: Extruded snack with lentil flour
60% corn flour and 40% lentil flour
Pulse extruded snack
Experimental: Extruded snack navy bean flour
60% corn flour and 40% navy bean flour
Pulse extruded snack
Experimental: Extruded snack with pinto bean flour
60% corn flour and 40% pinto bean flour
Pulse extruded snack

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Plasma Glucose and Insulin Concentrations
Time Frame: 0 - 240 min
Measured in blood using intravenous catheter at 14 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure)
0 - 240 min
Food Intake
Time Frame: at 120 min
Ad-libitum meal. Food consumed measured by weight.
at 120 min
Subjective Appetite
Time Frame: 0-240 min
Measured by VAS questionnaire at 14 time points, used to calculate area under curve (AUC).( Composite measure)
0-240 min
Exercise intensity
Time Frame: 60 minutes
Sixty minute exercise protocol at minutes 60 to 120. Oxygen consumption measured during exercise at 3 time points.
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Palatability of treatments
Time Frame: at 5 minutes
Measured by VAS questionnaire
at 5 minutes
Lactate concentration
Time Frame: 60 minutes
60 minute exercise protocol at minutes 60 to 120. Measured before, during, and exercise exercise at 3 time points
60 minutes
Palatability of meal
Time Frame: at 260 minutes
Measured by VAS questionnaire
at 260 minutes
Physical comfort
Time Frame: 0-240 min
Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
0-240 min
Energy/fatigue
Time Frame: 0-240 min
Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure)
0-240 min
Heart rate
Time Frame: 60-120 min
Heart rate monitored over a 60 minute exercise protocol. To monitor exercise intensity and give a measure of fatigue (cardiovascular drift)
60-120 min
Substrate Oxidation
Time Frame: 60 minutes
Measured during 60 minute exercise protocol at minutes 60-120. Respiratory quotient measured during exercise at 3 time points.
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Actual)

July 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

December 17, 2014

First Submitted That Met QC Criteria

March 24, 2015

First Posted (Estimate)

March 30, 2015

Study Record Updates

Last Update Posted (Actual)

January 23, 2023

Last Update Submitted That Met QC Criteria

January 19, 2023

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • B2014:114-2

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Control

3
Subscribe